← Back to Search

Group Self-Management Support for Anxiety Disorders

N/A
Waitlist Available
Led By Pasquale Roberge, Ph.D.
Research Sponsored by Université de Sherbrooke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Severe depressive symptoms
Cognitive impairment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, post-treatment, and 8-month, 12-month, 24-month post-randomization follow-ups
Awards & highlights

Summary

This trial aims to study if a virtual group self-management support program can help people with anxiety disorders when added to their usual treatment. The study will evaluate the effectiveness and cost of this program compared to standard

Who is the study for?
This trial is for adults over 18 in Quebec who speak French and have been diagnosed with anxiety disorders like Panic Disorder, Agoraphobia, Generalized Anxiety Disorder, or Social Anxiety Disorder. They must have internet access and a device with a microphone and camera to participate.
What is being tested?
The study tests a virtual group self-management support program as an addition to usual care for managing anxiety. It's compared against the standard treatment without this program. The effectiveness will be measured at different intervals up to two years after starting.
What are the potential side effects?
Since the intervention involves educational and self-help strategies rather than medication, no direct medical side effects are expected. Participants may experience discomfort discussing personal experiences or temporary increases in anxiety when confronting their symptoms.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am experiencing severe depression.
Select...
I have trouble with memory or thinking clearly.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, post-treatment, and 8-month, 12-month, 24-month post-randomization follow-ups
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, post-treatment, and 8-month, 12-month, 24-month post-randomization follow-ups for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Beck Anxiety Inventory (BAI)
Secondary outcome measures
Change in Administrative databases records
Change in Assessment of Quality of Life - 6 Dimensions
Change in Beck Anxiety Inventory
+5 more
Other outcome measures
Gross Cohesion Scale
Working Alliance Inventory

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group self-management supportExperimental Treatment1 Intervention
Group self-management support program for anxiety disorders developped by Relief (https://myrelief.ca/).
Group II: Treatment-as-usualActive Control1 Intervention
Treatment-as-usual and a delayed intervention (if desired by participants) after the 12-month follow up

Find a Location

Who is running the clinical trial?

Université de SherbrookeLead Sponsor
300 Previous Clinical Trials
69,539 Total Patients Enrolled
1 Trials studying Panic Disorder
231 Patients Enrolled for Panic Disorder
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,354 Previous Clinical Trials
26,460,105 Total Patients Enrolled
5 Trials studying Panic Disorder
4,373 Patients Enrolled for Panic Disorder
ReliefUNKNOWN
~142 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top